Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes infected individuals grouped according to CD4+ cell levels
- PMID: 1708780
- DOI: 10.1007/BF00918790
Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes infected individuals grouped according to CD4+ cell levels
Abstract
We examined sera from 160 HIV-infected individuals for antibodies reactive to HIV-1 gp160 epitopes defined by seven synthetic peptides. Seropositive individuals were placed into three groups based upon levels of circulating CD4+ cells. These groups consisted of individuals with (1) more than 400 CD4+ cells, (2) 200-400 CD4+ cells, and (3) fewer than 200 CD4+ cells/mm3. The percentage of sera containing antibodies reactive with two immunodominant gp160 epitopes (a.a. 304-321 and 600-611) was unchanged between groups, regardless of CD4 cell numbers. The percentage of sera containing antibodies reactive with weakly immunogenic gp160 epitopes, such as those defined by peptides 425-448 and 846-860, declined in the groups as CD4 values decreased. Our results suggest that the patterns of antibody reactivity to gp160 epitopes change as CD4 levels decline. A narrowing of the humoral immune response to epitopes on the envelope of HIV-1 appears to occur with disease progression.
Similar articles
-
Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States.J Clin Microbiol. 1992 Jan;30(1):126-31. doi: 10.1128/jcm.30.1.126-131.1992. J Clin Microbiol. 1992. PMID: 1370844 Free PMC article.
-
Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees.J Virol. 1990 Feb;64(2):486-92. doi: 10.1128/JVI.64.2.486-492.1990. J Virol. 1990. PMID: 2404138 Free PMC article.
-
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.J Virol. 1993 Mar;67(3):1693-7. doi: 10.1128/JVI.67.3.1693-1697.1993. J Virol. 1993. PMID: 7679751 Free PMC article.
-
How antibodies block HIV infection: paths to an AIDS vaccine.Trends Biochem Sci. 1992 May;17(5):191-6. doi: 10.1016/0968-0004(92)90265-b. Trends Biochem Sci. 1992. PMID: 1350693 Review.
-
Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression.Int Rev Immunol. 1992;8(1):65-81. doi: 10.3109/08830189209056642. Int Rev Immunol. 1992. PMID: 1374113 Review.
Cited by
-
Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression.Clin Diagn Lab Immunol. 1995 Jul;2(4):400-3. doi: 10.1128/cdli.2.4.400-403.1995. Clin Diagn Lab Immunol. 1995. PMID: 7583913 Free PMC article.
-
The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study.BMC Infect Dis. 2017 Mar 24;17(1):228. doi: 10.1186/s12879-017-2316-x. BMC Infect Dis. 2017. PMID: 28340570 Free PMC article. Clinical Trial.
-
Binding antibody responses to the immunogenic regions of viral envelope in HIV-1-infected Indian children.Viral Immunol. 2011 Dec;24(6):463-9. doi: 10.1089/vim.2011.0039. Viral Immunol. 2011. PMID: 22149971 Free PMC article.
-
Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States.J Clin Microbiol. 1992 Jan;30(1):126-31. doi: 10.1128/jcm.30.1.126-131.1992. J Clin Microbiol. 1992. PMID: 1370844 Free PMC article.
-
Evidence of simian virus 40 exposure in a colony of captive baboons.Virology. 2008 Jul 20;377(1):54-62. doi: 10.1016/j.virol.2008.03.035. Epub 2008 May 16. Virology. 2008. PMID: 18485439 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials